Cardio-Metabolic Diseases

Cardiometabolic syndrome (CMS) is a group of metabolic dysfunctions that are mainly characterized by insulin resistance, impaired glucose tolerance, dyslipidaemia, hypertension, and central adiposity. World Health Organization and the American Society of Endocrinology now recognized CMS as a disease entity. Patients with CMS have more chances to die from coronary heart disease, heart attack or stroke. Cardio metabolic programs and therapeutic strategies that combine diet and exercise prescriptions help to reduce cardiometabolic risk factors.  Treatment strategies include

  • Moderate physical activity
  • Weight reduction or Weight-Loss Surgery
  • Blood pressure control
  • Correction of dyslipidaemia
  • Glycaemic

Related Conference of Cardio-Metabolic Diseases

November 27-28, 2024

14th World Congress on Endocrinology and Diabetes

Paris, France
February 24-25, 2025

34th European Diabetes Congress

London, UK
March 10-11, 2025

4th Global Summit on Physiology and Metabolism of Thyroid

Singapore City, Singapore
March 17-18, 2025

5th European Endocrinology and Diabetes Congress

Paris, France
April 10-11, 2025

4th International Summit on Hormonal Disorders

Dubai, UAE
April 10-11, 2025

5th World Congress on Endocrine and Diabetes

Dubai, UAE
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland

Cardio-Metabolic Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in